ŁSŁukasz Starczewski

Łukasz Starczewski

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Łukasz Starczewski has a total of 24 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Large Language Models in Medicine: Opportunities, Limitations, and Future Directions – A Scoping Review

    by Antoni Klamka, Paulina Kawalec, Kamil Bronikowski, Maksymilian Ryszkowski, Krystian Fornal, Natalia BęDkowska-Kuśmierek, Sabina Zaborowska, Paulina Pawlak, Olaf Wojcieszuk, Łukasz Starczewski

    Introduction. Large language models (LLMs) are increasingly used in healthcare and health-related fields, including clinical decision support, personalized medicine, digital health, and sports performance monitoring. However, concerns regarding reliability, transparency, and safety continue to limit their broader implementation. Materials and Methods. A scoping review of 24 PubMed-indexed studies published between 2023 and 2026 was conducted to assess current applications, benefits, limitations, and future directions of LLMs in healthcare. Results. LLMs are being applied in clinical decision support, diagnostics, biomedical research, personalized healthcare, and digital health solutions. They can enhance information retrieval, clinical reasoning, literature synthesis, health monitoring, and sports-related applications such as training support and performance optimization. Emerging trends include retrieval-augmented generation, multimodal systems, and specialized AI agents. Key challenges include hallucinations, limited explainability, privacy concerns, and insufficient clinical validation. Conclusions. LLMs have significant potential to improve healthcare, biomedical research, and health-oriented sports applications. Currently, they should serve as supportive tools rather than autonomous decision-makers. Further progress requires robust validation, regulatory oversight, and effective human–AI collaboration.

  • Open Access

    Fecal Calprotectin: Beyond a Biomarker of Intestinal Inflammation

    by Kamil Bronikowski, Maksymilian Ryszkowski, Krystian Fornal, Natalia BęDkowska-Kuśmierek, Sabina Zaborowska, Paulina Pawlak, Olaf Wojcieszuk, Łukasz Starczewski, Adrianna Babik, Kamila Kamińska

    Background.Fecal calprotectin (FC), a neutrophil-derived S100A8/S100A9 heterodimer, is a widely used non-invasive biomarker of intestinal inflammation, particularly in inflammatory bowel diseases (IBD). Emerging evidence suggests its broader role in gut barrier dysfunction and systemic inflammation. Aim.To evaluate the clinical relevance of fecal calprotectin, focusing on its diagnostic performance, limitations, and emerging applications beyond IBD. Material and methods.A narrative review of PubMed-indexed literature was conducted, including original studies and reviews addressing the biological role of calprotectin, its diagnostic accuracy, and its association with intestinal permeability, microbiota, and metabolic inflammation. Results.Fecal calprotectin demonstrates high sensitivity for detecting intestinal inflammation and is useful in differentiating IBD from functional disorders such as irritable bowel syndrome. Its levels correlate with disease activity and are valuable in monitoring treatment response and predicting relapse. However, its specificity is limited, as elevated levels may occur in infections, malignancies, and drug-related mucosal injury. Recent studies suggest associations between FC, gut microbiota alterations, and low-grade systemic inflammation. Conclusions.Fecal calprotectin is a valuable tool in the diagnosis and management of intestinal inflammation. Its expanding role in systemic conditions highlights the need for further research to improve standardization and clarify its clinical applications

  • Open Access

    Endometriosis Beyond the Body: A Review of Its Impact on Mental Health, Sexual Function, and Fertility

    by Gabriela Babiarz, Damian Osiński, Zuzanna Kawa, Maria Kasprzak, Aleksandra JęDrzejewska, Aleksandra Jureczko, Klaudia Kleczaj, Łukasz Starczewski, Julia Jaworowska, Julia Kanarszczuk

    Introduction:Endometriosis is a chronic, hormone-dependent condition affecting up to 15% of women of reproductive age. It is associated with pain, infertility, and a significant reduction in quality of life. Despite increasing awareness, the average diagnostic delay remains between 7 and 11 years. The disease is characterized by chronic pelvic pain, fatigue, dyspareunia, and emotional distress, which may contribute to depression, anxiety, decreased self-esteem, and social isolation. Sexual dysfunction arises from both physical symptoms and psychological factors. Endometriosis is also recognized as a leading cause of infertility. Objective:The aim of this review is to evaluate the impact of endometriosis on women’s mental health, sexual functioning, and fertility, with particular emphasis on diagnostic delays and social stigma. Methods and materials: A literature review was conducted using publications available in the PubMed and Google Scholar databases from 2017-2025. The most relevant and recent studies were selected using appropriate keywords. Conclusions:Endometriosis requires a holistic and multidisciplinary approach that integrates medical management with psychological and sexual health support. Addressing mental health and social well-being is essential for improving overall quality of life in affected women. Early diagnosis and the reduction of stigma remain key challenges in contemporary clinical practice.

  • Open Access

    Leadership Styles in Sport: A Systematic Review

    by Krystian Fornal, Natalia BęDkowska-Kuśmierek, Sabina Zaborowska, Paulina Pawlak, Olaf Wojcieszuk, Łukasz Starczewski, Adrianna Babik, Kamila Kamińska, Matylda BęDkowska-Kuśmierek, Anna Złotnik

    Background: Leadership is a central determinant of performance, well-being, and organisational effectiveness in sport. Despite a growing body of empirical work, no comprehensive systematic review has synthesised findings across all sport-related leadership contexts, including coaching, physical education, and sport management.Objective: This systematic review aimed to identify, describe, and critically analyse the evidence base on leadership styles in sport published between 2010 and 2025.Methods: A systematic search was conducted in PubMed using a pre-specified Boolean search string in accordance with PRISMA 2020 guidelines [9]. A total of 105 records were retrieved. Following title, abstract, and full-text screening against pre-defined inclusion and exclusion criteria, 43 studies were included in the final synthesis.Results: Transformational leadership was the dominant paradigm, featuring in approximately 65% of included studies. Authentic and servant leadership emerged as important complementary constructs, particularly in relation to athlete well-being and shared leadership. Evidence on destructive leadership was sparse but highlighted significant negative consequences. Leadership research in sport management and governance contexts remained markedly underrepresented.Conclusions: The literature on leadership in sport is heavily skewed towards coach–athlete dyads and transformational leadership theory. Significant gaps remain in the study of leadership within sport organisations and federations, non-Western contexts, and emerging constructs such as paradoxical and ambidextrous leadership. Future research should adopt multi-level and longitudinal designs.

  • Open Access

    Physical activity as a non pharmacological intervention in Alzheimer’s disease: a narrative review

    by Sabina Zaborowska, Paulina Pawlak, Olaf Wojcieszuk, Łukasz Starczewski, Adrianna Babik, Kamila Kamińska, Matylda BęDkowska-Kuśmierek, Anna Złotnik, Kinga Krzysztofik, Antoni Klamka

    Background. Alzheimer’s disease (AD) is the leading cause of dementia, and disease‑modifying pharmacological options remain limited. Physical activity (PA) has emerged as a promising modifiable factor to mitigate cognitive decline and disease progression. Aim. To synthesize evidence from clinical and mechanistic studies on the effects of PA in AD, with emphasis on cognition, disease course, and key biological pathways. Material and methods. A targeted narrative search of PubMed and Scopus identified English‑language studies (2002–2025), prioritizing randomized controlled trials, systematic reviews, and meta‑analyses of exercise or PA interventions in individuals with AD, mild cognitive impairment, or preclinical AD; additional observational and mechanistic work was used to contextualize clinical findings. Evidence was synthesized qualitatively, without formal risk‑of‑bias assessment or quantitative meta‑analysis, focusing on cognition, neuropsychiatric symptoms, function, quality of life, and major mechanistic domains. Results. Most studies show that PA improves global cognition (especially executive function) and reduces neuropsychiatric symptoms, while memory effects are more limited. Resistance and multicomponent training yield greater cognitive benefits than aerobic exercise alone, likely via enhanced neurotrophic signaling, reduced Aβ/tau pathology, improved insulin sensitivity, attenuated neuroinflammation, and increased cerebral blood flow. Moderate‑intensity PA (≈150–180 min/week) appears optimal, slowing clinical progression most clearly in preclinical and mild AD, although effects on quality of life remain inconsistent. Conclusions. PA is a promising, safe, and accessible non‑pharmacological intervention, particularly in earlier AD stages, and should be considered a core component of strategies to reduce the burden of AD.

  • Open Access

    The role of Dupilumab in the treatment of Bullous Pemphigoid, Pemphigus and Hailey-Hailey Disease: A Narrative Review

    by Natalia BęDkowska-Kuśmierek, Sabina Zaborowska, Paulina Pawlak, Olaf Wojcieszuk, Łukasz Starczewski, Adrianna Babik, Kamila Kamińska, Anna Złotnik, Matylda BęDkowska-Kuśmierek, Kinga Krzysztofik

    Background: Autoimmune bullous diseases (AIBDs) and Hailey-Hailey disease are chronic skin disorders characterized by blister formation, pruritus, and reduced quality of life. Standard treatments, including systemic corticosteroids and immunosuppressants, often cause adverse effects and may not achieve long-term remission. Dupilumab, a monoclonal antibody targeting IL-4 and IL-13, has emerged as a promising alternative. Aim: To evaluate the efficacy and safety of dupilumab in patients with bullous pemphigoid, pemphigus vulgaris and foliaceus, and Hailey-Hailey disease. Material and Methods: Literature review including meta-analyses, randomized trials, retrospective studies, and case reports on dupilumab use in AIBDs and Hailey-Hailey disease. Disease activity was assessed using PDAI, BPDAI, or clinical evaluation; quality of life and adverse events were summarized. Results: In bullous pemphigoid, dupilumab reduced disease activity, pruritus, and cumulative corticosteroid dose, with most patients achieving complete or partial remission. Evidence in pemphigus vulgaris and foliaceus is limited but suggests potential benefit, particularly in patients ineligible for rituximab. In Hailey-Hailey disease, dupilumab improved lesions and quality of life, although relapse after discontinuation was reported. Therapy was generally well tolerated- with main adverse events being: injection site reactions, conjunctivitis, and eosinophilia. Conclusions: Dupilumab is an effective and safe option in bullous pemphigoid, offering pruritus relief and steroid-sparing benefits. Its use in pemphigus and Hailey-Hailey disease is promising but experimental. Further high-quality studies are needed to confirm long-term efficacy and safety.

  • Open Access

    The Impact of Lifestyle on Proper Thyroid Gland Function

    by Julia Kanarszczuk, Zuzanna Kawa, Maria Kasprzak, Aleksandra JęDrzejewska, Aleksandra Jureczko, Klaudia Kleczaj, Łukasz Starczewski, Julia Jaworowska, Gabriela Babiarz, Damian Osiński

    Introduction. Lifestyle significantly influences the functioning of the thyroid gland, especially in the case of hypothyroidism. Regular physical activity, a proper diet, an adequate amount of sleep and stress reduction can contribute to improving hormonal test results and alleviating the symptoms of this condition. Recent studies also highlight the role of vitamin D and gut microbiota. Their proper levels and the balance of microorganisms in the gut may support the immune system and influence hormonal regulation. A balanced diet rich in essential micronutrients, such as iodine, selenium, and zinc is an important element supporting therapy. This paper provides an overview of current scientific reports on the impact of selected lifestyle factors on the course of hypothyroidism. Available research results suggest that modifying daily habits can be a significant supplement to therapy, positively affecting the functioning of the thyroid gland and the quality of life of patients.Research objective. The objective of this review is to summarize the current scientific evidence concerning the impact of selected lifestyle factors on thyroid gland function.Conclusions. Based on the analysis of the available literature, it can be concluded that lifestyle plays a significant role during hypothyroidism and in maintaining the proper functioning of the thyroid gland. A well-balanced diet, regular physical activity and effective reduction of chronic stress may support therapy, positively influence hormonal balance and contribute to the alleviation of disease symptoms. Furthermore, an increasing number of studies highlight the importance of maintaining adequate vitamin D levels and gut microbiota balance in the regulation of thyroid function and support of the immune system. Therefore, the modification of daily habits constitutes an important adjunct to the treatment of hypothyroidism and may contribute to improving patients’ quality of life.

  • Open Access

    Metformin as a Potential Geroprotective Agent: Mechanisms, Clinical Evidence and Implications for Healthy Aging

    by Paulina Kawalec, Kamil Bronikowski, Maksymilian Ryszkowski, Krystian Fornal, Natalia BęDkowska-Kuśmierek, Sabina Zaborowska, Paulina Pawlak, Olaf Wojcieszuk, Łukasz Starczewski, Adrianna Babik

    Background: Population aging represents a major medical and socioeconomic challenge worldwide. The increasing prevalence of age-related diseases, including cardiovascular disorders, neurodegeneration, cancer, and metabolic dysfunction, highlights the need for strategies aimed at extending healthspan rather than lifespan alone. In this context, pharmacological agents that modulate fundamental biological processes of aging have attracted significant attention. Metformin has emerged as a potential candidate beyond its established role in the treatment of type 2 diabetes mellitus. Aim: This narrative review aimed to evaluate current evidence regarding the potential geroprotective properties of metformin, with particular emphasis on underlying molecular mechanisms and available clinical data. Materials and Methods: A narrative literature review was conducted using the PubMed database. Articles published between January 2015 and March 2025 were identified using the keywords “metformin”, “aging”, “longevity”, and “geroprotection”. Peer-reviewed original studies and review articles in English were included, while case reports and non-peer-reviewed publications were excluded. Results: Evidence indicates that metformin influences multiple pathways involved in aging, including activation of AMP-activated protein kinase (AMPK), inhibition of the mechanistic target of rapamycin (mTOR), modulation of mitochondrial metabolism, reduction of oxidative stress, and attenuation of chronic inflammation. Observational studies suggest associations with reduced incidence of age-related diseases and improved survival; however, direct evidence in non-diabetic populations remains limited. Conclusions: Metformin demonstrates properties consistent with potential geroprotective effects. However, well-designed randomized controlled trials are required to confirm its efficacy and safety in the context of healthy aging.

  • Open Access

    Physical activity and pharmacological interventions in reversing stress-induced hippocampal atrophy: An analysis of molecular mechanisms

    by Paulina Pawlak, Olaf Wojcieszuk, Łukasz Starczewski, Adrianna Babik, Kamila Kamińska, Matylda BęDkowska-Kuśmierek, Anna Złotnik, Kinga Krzysztofik, Antoni Klamka, Paulina Kawalec

    Background: Chronic stress, unlike its acute adaptive form, leads to a persistent disruption of homeostasis and an increasing allostatic load. A central component of the biological response to stress is the activation of the hypothalamic-pituitary-adrenal (HPA) axis, which leads to the release of glucocorticoids, particularly cortisol. The hippocampus, due to its high density of glucocorticoid receptors, becomes one of the main target structures for cortisol action. Its chronic excess becomes neurotoxic to the hippocampal structure and leads to its atrophy. Aim:The aim of this study is to analyze the mechanisms leading to hippocampal damage and to evaluate the clinical evidence regarding the reversibility of these changes through pharmacological and non-pharmacological interventions. Material and methods:The literature review was conducted by searching the electronic databases PubMed and Google Scholar. The search process utilized a combination of the logical operators AND/OR and the following keywords: chronic stress, cortisol, hippocampal atrophy, neuroplasticity, HPA axis, BDNF, physical exercise. Results: Chronic exposure to cortisol leads to dendritic atrophy, loss of synaptic spines, and inhibition of neurogenesis within the hippocampus. Recent reports, however, highlight the key role of the mTORC1 signaling pathway and BDNF expression in reversing these deficits. While psychoplastogens such as ketamine promote rapid synaptic remodeling, regular physical activity facilitates sustained structural adaptations.Conclusions: Hippocampal damage caused by chronic stress is not a completely irreversible process. The transition from a neurotoxic state to structural regeneration is possible through multi-track molecular pathways activated by both modern pharmacotherapy and systematic physical activity. This synergy opens new perspectives in education and sports medicine, aiming at the biological reconstruction of brain structures and improvement of the quality of life.

  • Open Access

    BPC-157 and GHK-Cu in Wound Healing and Tissue Repair: A Review of Clinical Efficacy and Safety

    by Olaf Wojcieszuk, Łukasz Starczewski, Adrianna Babik, Kamila Kamińska, Matylda BęDkowska-Kuśmierek, Anna Złotnik, Kinga Krzysztofik, Antoni Klamka, Paulina Kawalec, Kamil Bronikowski

    Background: BPC-157 and GHK-Cu are synthetic peptides with potential in tissue repair, influencing molecular mechanisms in healing, angiogenesis and inflammation. Objective: This review synthesizes preclinical and clinical research on BPC-157 and GHK-Cu efficacy and safety in wound healing and tissue repair, examining mechanistic pathways and translational potential in clinical and sports medicine. Methods: Literature searches of PubMed, Embase and Cochrane Library included studies on wound healing, tissue regeneration, safety and clinical uses of BPC-157 and GHK-Cu without publication date restrictions. Results: Preclinical studies show BPC-157 promotes skin, tendon, muscle and bone healing via specific signaling pathways and growth factor upregulation. GHK-Cu enhances collagen/elastin synthesis, angiogenesis and fibroblast migration. Limited human trials evaluated BPC-157 for knee pain and IV safety, while GHK-Cu showed promise in skin quality trials. Both appear safe but lack comprehensive RCTs. Conclusion: BPC-157 and GHK-Cu show therapeutic potential in wound healing, though evidence is largely preclinical. Extensive human trials are needed to establish clinical efficacy. This review provides groundwork for future research and highlights safety for sports medicine practitioners.